The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute
Issue link: https://lifescienceleadermag.epubxp.com/i/183480
2013 CMO Leadership Awards Winner Profiles DRUG TYPE: Pharmaceuticals and Biopharmaceuticals Catalent Pharma Solutions Somerset, NJ Manufacturing locations: Germany, United Kingdom, and United States www.catalent.com +44 0 1793 864000 Contact: Chris Halling media@catalent.com DRUG LIFE CYCLE STAGES: Research & Development — preclinical, clinical (phase 1, phase 2, and phase 3); Formulated Drug Production — dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, capsules, controlled substances, cytotoxic & high-potency compounds, generics, injectables, liquids, lyophilized products, nonsterile, ophthalmics, OTC, parenterals (large volume), parenterals (small volume), peptides, powders (sterile), proteins, semisolids, soft gels, solid dose, solutions & suspensions, sterile, sustained release, syringes (prefilled), and topicals. ÒWe are thrilled to again be recognized by pharmaceutical and biopharmaceutical leaders throughout the industry. Our innovative drug delivery technologies are built upon a solid foundation of reliability that spans our global network. Catalent has become a trusted partner through consistently demonstrating excellence in all areas of safety, quality, delivery, and cost. Our world-class programs in these areas set the tone of discipline that carries through everything that we do, ensuring customer satisfaction and trust.Ó Ñ Steve Leonard, SVP global operations Cedarburg Hauser Pharmaceuticals Grafton, WI Manufacturing locations: Denver, CO and Grafton, WI www.cedarburghauser.com (262) 376-1467 DRUG TYPE: Pharmaceuticals Contact: Bob Forner bob.forner@cedarburgpharma.com DRUG LIFE CYCLE STAGES: Drug Substance Production — primary process development and drug substance production SERVICES OFFERED: Controlled substances, cytotoxic & high-potency compounds, and generics. ÒProductivity is vital to Cedarburg HauserÕs success, as it allows us to deliver on-time solutions to our customers. At Cedarburg Hauser, productivity is ensured with a project management team that effectively brings together scientists and operational resources to meet and exceed our customerÕs expectations. Receiving a CMO Leadership Award in productivity for a second consecutive year is a testament to the hard work of our team.Ó Ñ Tony Laughrey, CEO DRUG TYPE: Pharmaceuticals and Biopharmaceuticals CEPiA Sanofi Bridgewater, NJ Manufacturing locations: France, Germany, Hungary, United Kingdom, United States, and several others www.cepia-sanofi.com (908) 981-4140 Contact: Edward King Edward.king@sanofi.com DRUG LIFE CYCLE STAGES: Research & Development — clinical (phase 2 and phase 3); Drug Substance Production — primary process development and drug substance production; Formulated Drug Production — dosage form development, dosage form production, and packaging SERVICES OFFERED: Aseptic fill/finish, capsules, cartridges, controlled substances, creams & ointments, cytotoxic & high-potency compounds, gels, generics, injectables, lyophilized products, nonsterile, ophthalmics, OTC, parenterals (large volume), parenterals (small volume), peptides, powders (nonsterile), proteins, solid dose, sterile, sustained release, syringes (prefilled), topicals, and vaccines. ÒAs a major CMO, Sanofi CEPiA continues to base its success on its strengths: a strong commitment to quality and regulatory compliance, as well as technical innovation. Both API and drug products are manufactured with the highest quality standards and strict regulatory compliance. Sanofi CEPiA customers receive the highest quality products and are provided with outstanding customer service.Ó Ñ Jacques Tavernier, vice president 36 The CMO Leadership Awards 2013